GYRE · CIK 0001124105 · operating
GYRE THERAPEUTICS, INC. (GYRE) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $844 million, GYRE THERAPEUTICS, INC. is a small-cap company. The stock currently trades at $8.76, up 6.31% today, with a 52-week range of $6.11–$13.75. The company trades at a trailing P/E of 219.0x and a forward P/E of 19.0x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $0.05 | $0.14 | +103.5% | |
| 2023 | $-1.41 | $-1.41 | -442.3% | |
| 2022 | $-0.26 | $-0.26 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | $-0.14 | +70.2% | |
| 2013 | $-0.47 | $-0.40 | +0.0% | |
| 2012 | $-0.47 | $-0.47 | -74.1% | |
| 2011 | $-0.27 | $-0.27 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-17 | 0000950170-25-040279 | SEC ↗ |
| 2023-12-31 | 2024-03-27 | 0000950170-24-037242 | SEC ↗ |
| 2022-12-31 | 2023-03-30 | 0001564590-23-004830 | SEC ↗ |
| 2021-12-31 | 2022-03-31 | 0001564590-22-012877 | SEC ↗ |
| 2020-12-31 | 2021-03-04 | 0001564590-21-010823 | SEC ↗ |
| 2019-12-31 | 2020-02-20 | 0001564590-20-005546 | SEC ↗ |
| 2018-12-31 | 2019-03-08 | 0001564590-19-006879 | SEC ↗ |
| 2017-12-31 | 2018-03-19 | 0001564590-18-006216 | SEC ↗ |
| 2016-12-31 | 2017-03-08 | 0001564590-17-003722 | SEC ↗ |
| 2015-12-31 | 2016-03-09 | 0001193125-16-498295 | SEC ↗ |
| 2014-12-31 | 2015-03-16 | 0001193125-15-093871 | SEC ↗ |
| 2013-12-31 | 2014-03-14 | 0001193125-14-099974 | SEC ↗ |
| 2012-12-31 | 2013-03-15 | 0001193125-13-109464 | SEC ↗ |